Home MolMed a new patent on its anticancer NGR-hTNF
 

Keywords :   


MolMed a new patent on its anticancer NGR-hTNF

2013-09-11 20:07:47| Logistics - Topix.net

MolMed S.p.A. announces today receipt of the official notification from the European Patent Office of the decision to grant a patent covering the therapeutic use of its investigational anticancer drug NGR-hTNF at low doses.

Tags: patent anticancer

Category:Transportation and Logistics

Latest from this category

All news

01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Hurricane Beryl Update Statement
01.07Hurricane Beryl Graphics
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Hurricane Beryl Public Advisory Number 11A
01.07Atlantic Tropical Weather Outlook
01.07Eastern North Pacific Tropical Weather Outlook
01.07Tropical Depression Chris Graphics
Transportation and Logistics »
01.07Hurricane Beryl Update Statement
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07BASFs TECH Academy Introduces Louisiana High School Students to Technical Careers
01.07Comericas Patterson Helps Entrepreneurs Grow Their Waste and Recycling Businesses
01.07Hitachi Zosen Inova Acquires Babcock & Wilcox's Denmark-Based Renewable Parts and Services Subsidiary
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 11A
01.07Summary for Hurricane Beryl (AT2/AL022024)
More »